Trials / Terminated
TerminatedNCT00677872
An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Epix Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
A 3-month open label study to evaluate the safety and efficacy of PRX-08066 in patients with pulmonary hypertension and COPD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PRX-08066 |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2008-12-01
- First posted
- 2008-05-15
- Last updated
- 2009-07-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00677872. Inclusion in this directory is not an endorsement.